Gallbladder cancer (GBC) is a rare form of cancer with no signs or symptoms in the early stages. In the U.S., approximately 2,000 people die annually from this condition, with only 20% diagnosed at an early stage. Surgery remains the most effective treatment. Although minimally invasive approaches—laparoscopic and robotic—are increasingly used in gastrointestinal oncology, their use in GBC is limited and comparing robotic surgery to laparoscopic and conventional surgery approaches remains limited and controversial.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗